Medpace Holdings Stock Analysis

Medpace Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.14. Medpace Holdings recorded earning per share (EPS) of 15.27. The entity had not issued any dividends in recent years. Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5000 people. To find out more about Medpace Holdings contact August MD at 513 579 9911 or learn more at https://www.medpace.com.

Medpace Holdings Investment Alerts

Medpace Largest EPS Surprises

View All Earnings Estimates

Medpace Holdings Environmental, Social, and Governance (ESG) Scores

Medpace Stock Institutional Investors

Note, although Medpace Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Medpace Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 12.67 B.

Medpace Profitablity

The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22.

Management Efficiency

Medpace Holdings has return on total asset (ROA) of 0.164 % which means that it generated a profit of $0.164 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.7024 %, meaning that it created $0.7024 on every $100 dollars invested by stockholders. Medpace Holdings' management efficiency ratios could be used to measure how well Medpace Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/21/2026, Return On Tangible Assets is likely to grow to 0.37. Also, Return On Capital Employed is likely to grow to 0.89. At this time, Medpace Holdings' Total Current Liabilities is relatively stable compared to the past year. As of 02/21/2026, Non Current Liabilities Total is likely to grow to about 174.7 M, while Liabilities And Stockholders Equity is likely to drop slightly above 1.5 B.

Technical Drivers

As of the 21st of February, Medpace Holdings secures the Mean Deviation of 1.68, risk adjusted performance of (0.09), and Standard Deviation of 2.74. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medpace Holdings, as well as the relationship between them.

Medpace Holdings Price Movement Analysis

Medpace Holdings Insider Trading Activities

Medpace Holdings Outstanding Bonds

Medpace Holdings Predictive Daily Indicators

Medpace Holdings Corporate Filings

Medpace Holdings Forecast Models

Medpace Holdings' time-series forecasting models are one of many Medpace Holdings' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medpace Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Medpace Holdings Bond Ratings

Medpace Holdings financial ratings play a critical role in determining how much Medpace Holdings have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Medpace Holdings' borrowing costs.

Medpace Holdings Debt to Cash Allocation

Medpace Holdings currently holds 250.5 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Medpace Holdings has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Medpace Holdings' use of debt, we should always consider it together with its cash and equity.

Medpace Holdings Common Stock Shares Outstanding Over Time

Medpace Holdings Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Medpace Holdings uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Medpace Holdings Debt Ratio

18.0

It seems most of the Medpace Holdings' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Medpace Holdings' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Medpace Holdings, which in turn will lower the firm's financial flexibility.

Medpace Holdings Corporate Bonds Issued

Medpace Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medpace Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medpace shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medpace Holdings. By using and applying Medpace Stock analysis, traders can create a robust methodology for identifying Medpace entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Medpace analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Medpace analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Medpace Holdings stock analysis indicators help investors evaluate how Medpace Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Medpace Holdings shares will generate the highest return on investment. By understating and applying Medpace Holdings stock analysis, traders can identify Medpace Holdings position entry and exit signals to maximize returns.

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.